Alloantigen-Pulsed Host Dendritic Cells Induce T-Cell Regulation and Prolong Allograft Survival in a Rat Model of Hindlimb Allotransplantation

Journal of Surgical Research

Volumn 153, Issue 2, 2009, Pages 317-325

  Kuo, Yur Ren ^a   Huang, Chong Wei ^a   Goto, Shigeru ^b   Wang, Chun Ting ^a   Hsu, Li Wen ^b   Lin, Yu Chun ^b   Yang, Kuender D ^a   Chen, Chao Long ^b   Lee, W P Andrew ^c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

composite tissue allotransplantation; dendritic cell; T cell regulation

Indexed keywords

ALLOANTIGEN; CYCLOSPORIN A; LYMPHOCYTE ANTIBODY; TRANSCRIPTION FACTOR FOXP3;

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPSY TECHNIQUE; BONE MARROW; CD4+ CD25+ T LYMPHOCYTE; CONTROLLED STUDY; DENDRITIC CELL; DESQUAMATION; DOSE RESPONSE; DRUG TOLERABILITY; EPIDERMOLYSIS; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; LYMPHOCYTE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD4; ANTILYMPHOCYTE SERUM; CHIMERISM; COMBINED MODALITY THERAPY; CYCLOSPORINE; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HINDLIMB; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; ISOANTIGENS; MALE; RATS; RATS, INBRED LEW; T-LYMPHOCYTES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 67349216663     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.05.034     Document Type: Article

References (29)

1. Lee W.P. Composite tissue transplantation: More science and patience needed. Plast Reconstr Surg 107 (2001) 1066
2. Jones N.F. Concerns about human hand transplantation in the 21st century. J Hand Surg [Am] 27 (2002) 771
3. Dubernard J.M., Owen E., Herzberg G., et al. Human hand allograft: Report on first 6 months. Lancet 353 (1999) 1315
4. Jones J.W., Gruber S.A., Barker J.H., et al. Successful hand transplantation. One-year follow-up. Louisville Hand Transplant Team. New Engl J Med 343 (2000) 468
5. Gorantla V.S., Barker J.H., Jones Jr. J.W., et al. Immunosuppressive agents in transplantation: Mechanisms of action and current anti-rejection strategies. Microsurgery 20 (2000) 420
6. Kaufman D.B., Shapiro R., Lucey M.R., et al. Immunosuppression: practice and trends. Am J Transplant 4 Suppl 9 (2004) 38
7. Sayegh M.H., and Carpenter C.B. Transplantation 50 years later-Progress, challenges, and promises. New Engl J Med 351 (2004) 2761
8. Lee W.P., Yaremchuk M.J., Pan Y.C., et al. Relative antigenicity of components of a vascularized limb allograft. Plast Reconstr Surg 87 (1991) 401
9. Morelli A.E., and Thomson A.W. Dendritic cells: Regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 196 (2003) 125
10. Groux H., Fournier N., and Cottrez F. Role of dendritic cells in the generation of regulatory T cells. Semin Immunol 16 (2004) 99
11. Olszewski W.L. Tolerogenic properties of dendritic cells in allografting. Ann Transplant 8 (2003) 5
12. Fu F., Li Y., Qian S., et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. Transplantation 62 (1996) 659
13. Garrovillo M., Ali A., and Oluwole S.F. Indirect allorecognition in acquired thymic tolerance: Induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. Transplantation 68 (1999) 1827
14. Nguyen V.T., Taieb A., Sacks J.M., et al. Allopeptide-pulsed dendritic cells and composite tissue allograft survival. Microsurgery 27 (2007) 105
15. Sacks J.M., Kuo Y.R., Taieb A., et al. Prolongation of composite tissue allograft survival by immature recipient dendritic cells pulsed with donor antigen and transient low-dose immunosuppression. Plast Reconstr Surg 121 (2008) 37
16. Lee W.P., Butler P.E., Randolph M.A., et al. Donor modification leads to prolonged survival of limb allografts. Plast Reconstr Surg 108 (2001) 1235
17. Buttemeyer R., Jones N.F., Min Z., et al. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine. Plast Reconstr Surg 97 (1996) 139
18. Jones N.F., Hebebrand D., Buttemeyer R., et al. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: Implications for clinical composite tissue transplantation. Plast Reconstr Surg 107 (2001) 777
19. Siemionow M.Z., Izycki D.M., and Zielinski M. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol. Transplantation 76 (2003) 1662
20. Kanaya K., Tsuchida Y., Inobe M., et al. Combined gene therapy with adenovirus vectors containing CTLA4Ig and CD40Ig prolongs survival of composite tissue allografts in rat model. Transplantation 75 (2003) 275
21. Steinman R.M., Hawiger D., and Nussenzweig M.C. Tolerogenic dendritic cells. Annu Rev Immunol 21 (2003) 685
22. Hackstein H., and Thomson A.W. Dendritic cells: Emerging pharmacological targets of immunosuppressive drugs. Nat Rev Immunol 4 (2004) 24
23. Morelli A.E., Hackstein H., and Thomson A.W. Potential of tolerogenic dendritic cells for transplantation. Semin Immunol 13 (2001) 323
24. Thomson A.W., Lu L., Wan Y., et al. Identification of donor-derived dendritic cell progenitors in bone marrow of spontaneously tolerant liver allograft recipients. Transplantation 60 (1995) 1555
25. Peche H., Trinite B., Martinet B., et al. Prolongation of heart allograft survival by immature dendritic cells generated from recipient type bone marrow progenitors. Am J Transplant 5 (2005) 255
26. Taner T., Hackstein H., Wang Z., et al. Rapamycin-treated, alloantigen-pulsed host dendritic cells induce ag-specific T cell regulation and prolong graft survival. Am J Transplant 5 (2005) 228
27. Ikeguchi R., Sacks J.M., Unadkat J.V., et al. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance Immunosuppression. Transplantation 85 (2008) 237
28. Horibe E.K., Sacks J., Unadkat J., et al. Rapamycin-conditioned, alloantigen-pulsed dendritic cells promote indefinite survival of vascularized skin allografts in association with T regulatory cell expansion. Transpl Immunol 18 (2008) 307
29. Kuo Y.R., Sacks J.M., Wu W.S., et al. Porcine heterotopic composite tissue allograft transplantation as a large animal model for pre-clinical study. Chang Gung Med J 29 (2006) 268